Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palifermin schedules for oral mucositis prevention in multiple myeloma undergoing high-dose melphalan and autologous PBSCT
2006-003709-15Phase 3Completed
- Sponsor
- Sobi
- Start
- Sep 2006
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of palifermin in stomatitis (3 arms), sponsored by Sobi. Primary endpoint: Maximum severity of oral mucositis. Started Sep 2006; status: completed.
02
Drugs
palifermin
03
Conditions
stomatitis
Beyond the preview
Go deeper on 2006-003709-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003709-15.